As previously reported [22,23], MSCs, when mixed with tumor cells in a tumor-related microenvironment, differentiate into cancer-associated fibroblasts (CAFs) that produce VEGF, IL-6, TGFβ1, etc., resulting in pro-tumor activity. The gene discussed is TGFB1; the disease is neoplasm.